Patents
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
12/1997
12/31/1997WO1997049689A1 Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
12/31/1997WO1997027179A3 Antiretroviral bases
12/30/1997US5703224 Homonucleosides which are resistant to hydrolysis
12/30/1997US5703085 Xanthine derivatives
12/30/1997US5703084 Adenosine deaminase inhibitors
12/30/1997CA1339609C 2-substituted-4-substituted-1, 3-dioxolanes, synthesis and use thereof
12/23/1997US5700936 Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
12/23/1997US5700920 Carbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use and intermediates
12/17/1997EP0812844A2 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof
12/17/1997EP0717748B1 2' or 3'-deoxy and 2'-dideoxy-beta-l-pentafuranonucleoside compounds, method of preparation and application in therary, especially as anti-viral agents
12/17/1997EP0559845B1 Use of compounds in preventing endotoxin shock
12/17/1997CN1168138A Aryl and heteroaryl purine compounds
12/17/1997CN1036712C Process for preparation of £1R-(1alpha, 2beta, 3alpha)|-2-amino-9-£2,3-di(hydroxymethyl)-cyclobutyl|-1,9-dihydro-6H-purin-6-one as antiviral agent
12/16/1997US5698685 Morpholino-subunit combinatorial library and method
12/14/1997CA2179086A1 Substituted imidazoles as modulators of multi-drug resistance
12/11/1997WO1997046561A1 Improved methods for the synthesis of chemical compounds having pde-iv inhibitory activity
12/11/1997WO1997046560A1 Amide derivatives
12/11/1997DE19622737A1 Use of new and known xanthine derivatives
12/11/1997DE19622734A1 New aminated hydroxy-alkynyl-xanthine derivatives
12/10/1997EP0811624A1 Purine compounds and xanthine oxidase inhibitors
12/10/1997EP0811623A1 Xanthine derivatives with end-aminated alkynol side chains
12/10/1997EP0810884A1 Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
12/10/1997EP0693071B1 New carboxylic-acid esters of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine, the preparation of such esters and their use
12/09/1997US5696265 Antiretroviral; antitunor agent
12/09/1997US5696254 Processes for the diastereoselective synthesis of nucleoside analogues
12/09/1997US5696248 Gene expression inhibitor, as probes for detecting nucleic acids, as viricides treating viral disease caused by htlv, influenza, hepatitis virus, papilloma virus
12/09/1997US5696124 Xanthine derivatives with adenosine-antagonistic activity
12/04/1997WO1997045539A1 Probe for analysis of nucleic acids
12/04/1997WO1997045421A1 Oxocoumarin and barbituric acid derivates, their preparation and their use as ligand inhibitors of a corticotropin-releasing factor (crf) and/or a crf-binding protein complex
12/04/1997CA2254744A1 Oxocoumarin and barbituric acid derivates, their preparation and their use as ligand inhibitors of a corticotropin-releasing factor (crf) and/or a crf-binding protein complex
12/02/1997US5693798 Phosphonate nucleoside analogs
12/02/1997US5693787 Stereospecific
11/1997
11/27/1997WO1997044339A1 Antagonists of gonadotropin releasing hormone
11/27/1997WO1997044329A1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/27/1997WO1997044326A1 Aryl pyrimidine derivatives
11/27/1997CA2255705A1 Aryl pyrimidine derivatives
11/27/1997CA2254769A1 Antagonists of gonadotropin releasing hormone
11/25/1997US5691366 Unsaturated nitro oxime formed by reaction of dinitrogen trioxide with diolefin ether, sulfide or amine to be used as vasodilators
11/20/1997WO1997043257A1 Inhibitors of microsomal triglyceride transfer protein and method
11/19/1997EP0731807A4 N-2 substituted purines
11/19/1997EP0720604B1 Conformationally locked nucleoside analogues
11/18/1997US5688948 Intermediates for acyclovir and ganciclovir with crystallization
11/18/1997US5688947 Production of purines via reductive formylation
11/18/1997US5688802 Treatment of alzheimer's disease, organic brain syndrome, parkinson's disease, senile dementia
11/18/1997US5688778 Nucleoside analogs
11/12/1997EP0806425A1 An improved regiospecific process for synthesis of acyclic nucleosides
11/12/1997EP0805812A1 Bicyclic substituted hexahydrobenz(e)isoindole alpha-1- adrenergic antagonists
11/11/1997US5686629 Chemical intermediates
11/11/1997US5686611 Nucleoside analogs
11/05/1997EP0804436A1 Guanine derivative
11/05/1997EP0804427A1 Lta4 hydrolase inhibitors
11/05/1997EP0804199A1 Use of penciclorin for the treatment of post-therapeutic neuralgia
11/04/1997US5684164 Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
11/04/1997US5684153 Process for the preparation of purine derivatives
11/04/1997US5684010 Viricides
10/1997
10/29/1997EP0802914A1 Aryl and heteroaryl purine compounds
10/29/1997EP0802902A1 Indole derivatives useful in the treatment of osteoporosis
10/28/1997US5681941 Substituted purines and oligonucleotide cross-linking
10/28/1997US5681940 Sugar modified nucleosides and oligonucleotides
10/23/1997CA2251394A1 N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors
10/22/1997EP0801568A1 Compounds for inhibition of ceramide-mediated signal transduction
10/21/1997US5679684 Intiinflammatory agents, antiarthritis agents, nervous system disorders, aids
10/21/1997US5679683 Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
10/21/1997CA2016765C Antiviral, highly water soluble, stable, crystalline salts of 2',3'-dideoxyinosine monohydrate, 2',3'-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-fluoroinosine hemihydrate
10/21/1997CA1339506C Caffeine recovery from supercritical carbon dioxide
10/16/1997WO1997022619A3 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
10/08/1997EP0799040A1 Trisubstituted thioxanthines
10/08/1997EP0799039A1 Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections
10/08/1997EP0506892B1 Boronated nucleosides
10/08/1997CN1161694A Nucleoside derivatives and process for preparing same
10/08/1997CN1161321A Method for extracting tea polyphenol and by-products from tea leaves
10/07/1997US5675005 Cyclizing uracil derivative in solvent in the presence of lithium hydroxide
10/07/1997CA2009637C Substituted-1,3-oxathiolanes with antiviral properties
10/02/1997WO1997035846A1 Aryloxy- and arylthio-fused pyridines and pyrimidines and derivatives
10/02/1997WO1997035539A2 Arylamino fused pyridines and pyrimidines
10/02/1997CA2250241A1 Arylamino fused pyridines and pyrimidines
10/02/1997CA2249598A1 Aryloxy- and arylthio-fused pyridines and pyrimidines and derivatives
10/01/1997CN1160715A Synthsis of doxofylline
09/1997
09/30/1997US5672594 Anticarcinogenic,-tumor and -parasitic agents; viricides; fungicides; bactericides; hiv virus
09/30/1997CA1339483C Production of 2',3'-dideoxy-2',3'-didehydronucleosides
09/25/1997WO1997034891A1 Substituted 1,3-thiazolidines and 1,3-thiazolidin-4-ones, method for preparing same, and use thereof as drugs
09/24/1997EP0796099A1 Use of xanthine oxidase inhibitors as anti-ischaemic agents
09/24/1997CN1160402A Purine and guanine compounds as inhibitors of PNP
09/23/1997US5670506 Halogen, isothiocyanate or azide substituted xanthines
09/23/1997US5670501 Useful as diuretics, treating renal disorders, restoring cardiac functions
09/23/1997US5670498 8-substituted styryl xanthine derivatives
09/23/1997CA2069024C Processes for the diastereoselective synthesis of nucleosides
09/17/1997EP0794963A2 A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells
09/17/1997EP0794945A1 Iminooxybenzylcrotonic acid esters, process for their preparation and use thereof
09/17/1997EP0794781A1 Drugs to prevent recurrent herpes virus infections
09/17/1997CN1035877C 8-(1-aminocycloalkyl)-1,3-dialkylxanthine derivatives
09/16/1997US5668139 Xanthine derivatives
09/16/1997US5668113 Method of using 1,5-anhydrohexitol nucleoside analogues to treat viral infections
09/16/1997CA1339465C Electrochemiluminescent assays
09/10/1997EP0793498A1 Bicyclic heterocyclic compounds for the treatment of impotence
09/10/1997EP0793486A1 cGMP-PDE INHIBITORS FOR THE TREATMENT OF ERECTILE DYSFUNCTION
09/03/1997EP0792283A1 SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAs) AND ANALOGUES VIA SUBMONOMER APPROACH
09/02/1997US5663338 Process for preparing 2-amino-6-chloropurine
09/02/1997US5663320 Processes for the diastereoselective separation of nucleoside analogue synthetic intermediates
09/02/1997US5663175 Prodrugs of herpes TK inhibitors
1 ... 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 ... 120